Susquehanna International Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,100
| Closed | -$327K | – | 13676 |
|
|
2021
Q1 | $327K | Sell |
4,100
-20,800
| -84% | -$1.62M | ﹤0.01% | 10427 |
|
|
2020
Q4 | $1.96M | Sell |
24,900
-51,000
| -67% | -$2.99M | ﹤0.01% | 5141 |
|
|
2020
Q3 | $3.33M | Buy |
75,900
+8,400
| +12% | +$414K | ﹤0.01% | 3688 |
|
|
2020
Q2 | $2.99M | Buy |
67,500
+57,200
| +555% | +$2.13M | ﹤0.01% | 3814 |
|
|
2020
Q1 | $370K | Sell |
10,300
-31,600
| -75% | -$1.8M | ﹤0.01% | 7570 |
|
|
2019
Q4 | $2.97M | Buy |
41,900
+34,100
| +437% | +$2.47M | ﹤0.01% | 3713 |
|
|
2019
Q3 | $583K | Sell |
7,800
-6,200
| -44% | -$526K | ﹤0.01% | 6945 |
|
|
2019
Q2 | $1.13M | Sell |
14,000
-4,100
| -23% | -$288K | ﹤0.01% | 5383 |
|
|
2019
Q1 | $1.21M | Buy |
+18,100
| New | +$1.37M | ﹤0.01% | 4648 |
|
|
2018
Q4 | – | Sell |
-7,500
| Closed | -$690K | – | 10370 |
|
|
2018
Q3 | $690K | Sell |
7,500
-43,500
| -85% | -$4.14M | ﹤0.01% | 5961 |
|
|
2018
Q2 | $5.02M | Buy |
51,000
+49,100
| +2,584% | +$5.49M | ﹤0.01% | 2701 |
|
|
2018
Q1 | $212K | Sell |
1,900
-24,700
| -93% | -$2.77M | ﹤0.01% | 8231 |
|
|
2017
Q4 | $2.74M | Buy |
26,600
+21,100
| +384% | +$2.1M | ﹤0.01% | 3389 |
|
|
2017
Q3 | $518K | Buy |
5,500
+2,700
| +96% | +$213K | ﹤0.01% | 6448 |
|
|
2017
Q2 | $218K | Buy |
+2,800
| New | +$210K | ﹤0.01% | 8142 |
|
|
2016
Q4 | – | Sell |
-4,300
| Closed | -$335K | – | 10383 |
|
|
2016
Q3 | $335K | Buy |
+4,300
| New | +$312K | ﹤0.01% | 6753 |
|
Susquehanna International Group's CMD Position: Q2 2021 in Review
Susquehanna International Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 6,389 shares — an estimated $510K sold.
Susquehanna International Group first reported a position in CMD in Q2 2013 and held it in 27 quarters. The position peaked at $9.48M in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Susquehanna International Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Susquehanna International Group sold 6,389 Cantel Medical Corporation shares in Q2 2021, an estimated $510K.
- Susquehanna International Group first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 27 quarters.
- Susquehanna International Group's Cantel Medical Corporation position peaked at $9.48M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.